The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 02, 2024
Filed:
Feb. 28, 2020
Applicant:
Innate Pharma, Marseilles, FR;
Inventors:
Laurent Gauthier, Marseilles, FR;
Simon Kollnberger, Headington, GB;
Benjamin Rossi, Marseilles, FR;
Hélène Sicard, Marseilles, FR;
Carine Paturel, Marcy l'Étoile, FR;
Stéphanie Cornen, Marseilles, FR;
Stéphanie Zerbib, Marseilles, FR;
Assignee:
INNATE PHARMA, Marseilles, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); C07K 16/28 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); G01N 33/56966 (2013.01); G01N 33/56972 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); G01N 2333/70503 (2013.01); G01N 2800/24 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7095 (2013.01);
Abstract
The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same.